• 2017
  Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, McGlasson SL, Alyanakian MA, Bader-Meunier B, Barnerias C, Bellon N, Belot A, Bodemer C, Briggs TA, Desguerre I, Frémond ML, Hully M, van den Maagdenberg AMJM, Melki I, Meyts I, Musset L, Pelzer N, Quartier P, Terwindt GM, Wardlaw J, Wiseman S, Rieux-Laucat F, Rose Y, Neven B, Hertel C, Hayday A, Albert ML, Rozenberg F, Crow YJ, Duffy D, Detection of interferon alpha protein reveals differential levels and cellular sources in disease, J. Exp. Med. 2017 May;214(5):1547-1555.
• 2017
  Passaes CP, Bruel T, Decalf J, David A, Angin M, Monceaux V, Muller-Trutwin M, Noel N, Bourdic K, Lambotte O, Albert ML, Duffy D, Schwartz O, Sáez-Cirión A, , Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents, J. Virol. 2017 03;91(6).
• 2016
  Decalf J, da Silva RB, Werneke S, Albert ML, Comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”, Sci Transl Med 2016 Jul;8(349):349le1.
• 2016
  Decalf J, Tarbell KV, Casrouge A, Price JD, Linder G, Mottez E, Sultanik P, Mallet V, Pol S, Duffy D, Albert ML, Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies, EMBO Mol Med 2016 Jun;8(6):679-83.
• 2015
  Meissner EG, Decalf J, Casrouge A, Masur H, Kottilil S, Albert ML, Duffy D, Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy, PLoS ONE 2015;10(7):e0133236.
• 2014
  Decalf J, Godinho-Silva C, Fontinha D, Marques S, Simas JP, Establishment of murine gammaherpesvirus latency in B cells is not a stochastic event, PLoS Pathog. 2014 Jul;10(7):e1004269.
• 2014
  Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A, Eldin NS, Fontes M, Abdel-Hamid M, Mohamed MK, Rafik M, Fontanet A, Albert ML, The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis, Hepatology 2014 Apr;59(4):1273-82.
• 2013
  Gaudin R, Berre S, Cunha de Alencar B, Decalf J, Schindler M, Gobert FX, Jouve M, Benaroch P, Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections, PLoS ONE 2013;8(7):e69450.
• 2011
  Aubry C, Goulard C, Nahori MA, Cayet N, Decalf J, Sachse M, Boneca IG, Cossart P, Dussurget O, OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulence, J. Infect. Dis. 2011 Sep;204(5):731-40.
• 2010
  Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML, Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV, J. Clin. Invest. 2011 Jan;121(1):308-17.
• 2010
  Ribot JC, Chaves-Ferreira M, d'Orey F, Wencker M, Gonçalves-Sousa N, Decalf J, Simas JP, Hayday AC, Silva-Santos B, Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-γ- or IL-17-producing γδ T cells upon infection, J. Immunol. 2010 Dec;185(11):6421-5.
• 2010
  Mansour H, Laird ME, Saleh R, Casrouge A, Eldin NS, El Kafrawy S, Hamdy M, Decalf J, Rosenberg BR, Fontanet A, Abdel-Hamid M, Mohamed MK, Albert ML, Rafik M, Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype, J. Infect. Dis. 2010 Dec;202(11):1671-5.
• 2009
  Phillips R, Sarfo FS, Guenin-Macé L, Decalf J, Wansbrough-Jones M, Albert ML, Demangel C, Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease, J. Infect. Dis. 2009 Dec;200(11):1675-84.
• 2008
  Albert ML, Decalf J, Pol S, Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C, J. Hepatol. 2008 Dec;49(6):1069-78.
• 2008
  Neveu B, Debeaupuis E, Echasserieau K, le Moullac-Vaidye B, Gassin M, Jegou L, Decalf J, Albert M, Ferry N, Gournay J, Houssaint E, Bonneville M, Saulquin X, Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection, Hepatology 2008 Sep;48(3):713-22.
• 2007
  Coutanceau E, Decalf J, Martino A, Babon A, Winter N, Cole ST, Albert ML, Demangel C, Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone, J. Exp. Med. 2007 Jun;204(6):1395-403.